Viatris
Pfizer agrees to pay $50M to settle EpiPen price-fixing lawsuit
Anika Sharma
Pfizer has agreed to a $50 million settlement to resolve a class-action antitrust case dating back to 2020. The lawsuit, ...
Viatris challenges Novo Nordiskās patent on diabetes drug semaglutide
Anika Sharma
In Viatris’ ambitious bid to be the first to introduce generic versions of Novo Nordisk’s blockbuster diabetes and obesity drugs, ...
Viatris Divests in Major Restructure, Letting Go of 3 Units, 6,000 Staff, and 10 Plants
Anika Sharma
As Viatris charts its course to reposition itself as a focused eye care enterprise, the company is streamlining its operations ...
Viatris and Ocuphireās Ryzumvi gets FDA approval for reversing eye dilation
Anika Sharma
Viatris has achieved a significant milestone in its pursuit of reaching $1 billion in eye care sales by 2028. The ...
